Literature DB >> 11368906

Isolation and functional characterisation of the promoter region of the human prion protein gene.

S P Mahal1, E A Asante, M Antoniou, J Collinge.   

Abstract

The human prion protein gene (PRNP) encodes a 33-35 kDa cell surface protein that is highly expressed in the central nervous system and is vital to the pathogenesis of prion diseases. We have characterised the promoter region of PRNP as a first step towards defining the mechanisms regulating its expression. Sequence analysis of a 2.7 kb genomic DNA fragment containing exon I and the 5'-flanking region of PRNP, revealed a number of putative transcriptional factor binding sites, including Sp1, Ap-1, Ap-2 and a CCAAT box. Transient transfection assays in tissue culture cells with constructs consisting of the wild-type and deletion mutants of the PRNP 2.7 kb genomic fragment driving a luciferase reporter gene, demonstrate an active promoter within a 273 bp region (-148 to +125, relative to the cap site).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368906     DOI: 10.1016/s0378-1119(01)00424-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study.

Authors:  C Vollmert; O Windl; W Xiang; A Rosenberger; I Zerr; H-E Wichmann; H Bickeböller; T Illig; H A Kretzschmar
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

2.  Activation and repression of prion protein expression by key regions of intron 1.

Authors:  Josephine A Wright; Patrick C McHugh; Mark Stockbridge; Samantha Lane; Silvia Kralovicova; David R Brown
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

3.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

4.  Role of the cellular prion protein in the neuron adaptation strategy to copper deficiency.

Authors:  Emanuela Urso; Daniela Manno; Antonio Serra; Alessandro Buccolieri; Antonia Rizzello; Antonio Danieli; Raffaele Acierno; Benedetto Salvato; Michele Maffia
Journal:  Cell Mol Neurobiol       Date:  2012-02-24       Impact factor: 5.046

Review 5.  Gene expression and epigenetic markers of prion diseases.

Authors:  Emmanuelle A Viré; Simon Mead
Journal:  Cell Tissue Res       Date:  2022-03-21       Impact factor: 5.249

6.  Identification of a novel endoplasmic reticulum stress response element regulated by XBP1.

Authors:  Michael Misiewicz; Marc-André Déry; Bénédicte Foveau; Julie Jodoin; Derek Ruths; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

Review 7.  The role of the cellular prion protein in the immune system.

Authors:  J D Isaacs; G S Jackson; D M Altmann
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

8.  Two adjacent nuclear factor-binding domains activate expression from the human PRNP promoter.

Authors:  Michael J Taheny; Nerik Izkhakov; Alexander A Vostrov; Wolfgang W Quitschke
Journal:  BMC Res Notes       Date:  2009-09-09

9.  PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.

Authors:  Matthew T Bishop; Catherine Pennington; Craig A Heath; Robert G Will; Richard S G Knight
Journal:  BMC Med Genet       Date:  2009-12-26       Impact factor: 2.103

10.  Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer.

Authors:  Marc-André Déry; Julie Jodoin; Josie Ursini-Siegel; Olga Aleynikova; Cristiano Ferrario; Saima Hassan; Mark Basik; Andréa C LeBlanc
Journal:  Breast Cancer Res       Date:  2013-03-12       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.